A randomized controlled trial has shown that treatment of plaque psoriasis via costimulatory blockade ( CD28/B7) with abatacept did not prevent psoriasis relapse after withdrawal of ustekinumab. Read the full story on #RheumNow. https://t.co/8qgxYFW7EE https://t.co/8hi7JmR59a